Fortress Biotech Inc expected to post a loss of 20 cents a share - Earnings Preview

Fortress Biotech

10/08/2026 12:44

Fortress Biotech Inc FBIO.OQ FBIO.O is expected to  show a rise in quarterly revenue when it reports  results on August 12 (estimated) for the period ending June 30 2026
The Bay Harbor Islands Florida-based  company is expected to report a 11.5% increase in revenue to $18.3 million from $16.41 million a year ago, according to the estimate from one analyst, based on LSEG data.
​LSEG's mean analyst estimate for Fortress Biotech Inc is for a loss of 20 cents per share. 
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."  
The mean earnings estimate of analysts was unchanged in the last three months. ​
Wall Street's median 12-month price target for Fortress Biotech Inc is $11.00, about 312% above its last closing price of $2.67
This summary was machine generated August 10 at 11:44 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)